SEC 13F Intelligence

Syquant Capital Sas / PACB

Syquant Capital Sas’s Pacific Biosciences Calif In Position

Does Syquant Capital Sas own Pacific Biosciences Calif In (PACB)? Not currently — the last reported position was 712.2K shares worth $4M in Q2 2019; the fund’s latest 13F (Q2 2026) no longer reports it.

Position Value
$4M
Q2 2019
Shares
712.2K
% of Portfolio
+1.38%
Quarters Held
2
position exited

Position History PACB

Reported value by quarter
Q1 ’19: $4MQ1 ’19Q2 ’19: $4MQ2 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2019712.2K$4M+1.38%
Q1 2019496.1K$4M+1.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Syquant Capital Sas’s full portfolio or all institutional holders of PACB.